Skip to content
Screener

Vertex Pharmaceuticals VRTX Q1 2025 earnings

Reported May 5, 2025 · After market close

Revenue$2.8BMiss by $91.6M
EPS$4.06Miss by $0.19
Revenue estimate$2.9B
EPS estimate$4.25

Next report

Nov 2, 2026 (in a month)
Revenue estimate$3.4B
EPS estimate$4.76

Financials

Q1 2025

Income statement

See full
Revenue$2.8B+3.0%
Gross profit$2.4B+2.5%
Operating income$630.1M-44.7%
Net income$646.3M-41.2%
EPS (diluted)$2.49-40.9%

Balance sheet

See full
Cash & equivalents$4.7B-48.9%
Total debt$1.6B+129%
Total equity$16.5B-11.1%
Total assets$22.9B-4.3%

Cash flow

See full
Operating cash flow$818.9M-37.3%
CapEx$40.7M-40.5%
Free cash flow$778.2M-37.2%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$124.5B+15.3%
Enterprise value$121.46B+22.1%
P/S11.2×+0.6×

Profitability

See full
Gross margin86%-0.8pp
FCF margin-31%-67.5pp

Returns & leverage

See full
Debt / equity0.1×+0.1×
Current ratio2.6×-0.9×

Segments

By product

See full
TRIKAFTA/KAFTRIO$2.5B+2.1%
Other CF product revenues$155.3M—
ALYFTREK$53.9M—

By geography

See full
Europe$826.6M-14.6%
Other$280.1M—

By segment

See full
Pharmaceuticals$2.8B+3.0%

FAQ

When did Vertex Pharmaceuticals report Q1 2025 earnings?
Vertex Pharmaceuticals (VRTX) reported Q1 2025 earnings on May 5, 2025 after market close.
What were Vertex Pharmaceuticals's Q1 2025 revenue and EPS?
Vertex Pharmaceuticals reported revenue of $2.8B and eps of $4.06 for Q1 2025.
Did Vertex Pharmaceuticals beat estimates in Q1 2025?
Revenue missed the consensus estimate of $2.9B by $91.6M. EPS missed the consensus estimate of $4.25 by $0.19.
How did Vertex Pharmaceuticals's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.1% from $2.7B a year earlier and eps declined 14.7% from $4.76.
Where can I find Vertex Pharmaceuticals's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000875320-25-000171) and the 10-Q periodic report (0000875320-25-000192) directly on SEC EDGAR. The filing index links above go to sec.gov.